NORTH VANCOUVER, Sept. 23 /CNW/ - Chromos Molecular Systems Inc.
("Chromos" or the "Company") announced that the parties to the previously
announced plan of arrangement (the "Arrangement") involving, among others,
Chromos, Calyx Bio-Ventures Inc. ("Calyx"), a wholly-owned subsidiary of
Chromos, and Modatech Systems Inc. under section 288 of the Business
Corporations Act (British Columbia) have entered into an agreement to extend
the closing of the Arrangement as the parties continue to work towards the
satisfaction of related closing conditions. The closing of the Arrangement is
now currently scheduled to take place at the end of October 2008.
